Global Retapamulin Market Growth (Status and Outlook) 2025-2031

December 2025 | 72 pages | ID: G365D155BA7EN
LP Information

Abstracts

According to this study, the global Retapamulin market size will reach US$ million by 2031.

Retapamulin is a topical antibiotic developed by GlaxoSmithKline. It is the first drug in the new class of pleuromutilin antibiotics to be approved for human use. It is marketed as an ointment under the brand names Altabax and Altargo.

United States market for Retapamulin is estimated to increase from US$ million in 2024 to US$ million by 2031, at a CAGR of % from 2025 through 2031.

China market for Retapamulin is estimated to increase from US$ million in 2024 to US$ million by 2031, at a CAGR of % from 2025 through 2031.

Europe market for Retapamulin is estimated to increase from US$ million in 2024 to US$ million by 2031, at a CAGR of % from 2025 through 2031.

Global key Retapamulin players cover Almirall, etc. In terms of revenue, the global two largest companies occupied for a share nearly % in 2024.

LPI (LP Information)' newest research report, the “Retapamulin Industry Forecast” looks at past sales and reviews total world Retapamulin sales in 2024, providing a comprehensive analysis by region and market sector of projected Retapamulin sales for 2025 through 2031. With Retapamulin sales broken down by region, market sector and sub-sector, this report provides a detailed analysis in US$ millions of the world Retapamulin industry.

This Insight Report provides a comprehensive analysis of the global Retapamulin landscape and highlights key trends related to product segmentation, company formation, revenue, and market share, latest development, and M&A activity. This report also analyses the strategies of leading global companies with a focus on Retapamulin portfolios and capabilities, market entry strategies, market positions, and geographic footprints, to better understand these firms’ unique position in an accelerating global Retapamulin market.

This Insight Report evaluates the key market trends, drivers, and affecting factors shaping the global outlook for Retapamulin and breaks down the forecast by Type, by Application, geography, and market size to highlight emerging pockets of opportunity. With a transparent methodology based on hundreds of bottom-up qualitative and quantitative market inputs, this study forecast offers a highly nuanced view of the current state and future trajectory in the global Retapamulin.

This report presents a comprehensive overview, market shares, and growth opportunities of Retapamulin market by product type, application, key players and key regions and countries.

Segmentation by Type:

• 1% ointment(15-gram tubes)
• 1% ointment(30-gram tubes)

Segmentation by Application:

• Hospital
• Drug store

This report also splits the market by region:

• Americas
• United States
• Canada
• Mexico
• Brazil
• APAC
• China
• Japan
• Korea
• Southeast Asia
• India
• Australia
• Europe
• Germany
• France
• UK
• Italy
• Russia
• Middle East & Africa
• Egypt
• South Africa
• Israel
• Turkey
• GCC Countries

The below companies that are profiled have been selected based on inputs gathered from primary experts and analyzing the company's coverage, product portfolio, its market penetration.

• Almirall

Contents

1 SCOPE OF THE REPORT

1.1 Market Introduction
1.2 Years Considered
1.3 Research Objectives
1.4 Market Research Methodology
1.5 Research Process and Data Source
1.6 Economic Indicators
1.7 Currency Considered
1.8 Market Estimation Caveats

2 EXECUTIVE SUMMARY

2.1 World Market Overview
  2.1.1 Global Retapamulin Market Size (2020-2031)
  2.1.2 Retapamulin Market Size CAGR by Region (2020 VS 2024 VS 2031)
  2.1.3 World Current & Future Analysis for Retapamulin by Country/Region (2020, 2024 & 2031)
2.2 Retapamulin Segment by Type
  2.2.1 1% ointment(15-gram tubes)
  2.2.2 1% ointment(30-gram tubes)
2.3 Retapamulin Market Size by Type
  2.3.1 Retapamulin Market Size CAGR by Type (2020 VS 2024 VS 2031)
  2.3.2 Global Retapamulin Market Size Market Share by Type (2020-2025)
2.4 Retapamulin Segment by Application
  2.4.1 Hospital
  2.4.2 Drug store
2.5 Retapamulin Market Size by Application
  2.5.1 Retapamulin Market Size CAGR by Application (2020 VS 2024 VS 2031)
  2.5.2 Global Retapamulin Market Size Market Share by Application (2020-2025)

3 RETAPAMULIN MARKET SIZE BY PLAYER

3.1 Retapamulin Market Size Market Share by Player
  3.1.1 Global Retapamulin Revenue by Player (2020-2025)
  3.1.2 Global Retapamulin Revenue Market Share by Player (2020-2025)
3.2 Global Retapamulin Key Players Head office and Products Offered
3.3 Market Concentration Rate Analysis
  3.3.1 Competition Landscape Analysis
  3.3.2 Concentration Ratio (CR3, CR5 and CR10) & (2023-2025)
3.4 New Products and Potential Entrants
3.5 Mergers & Acquisitions, Expansion

4 RETAPAMULIN BY REGION

4.1 Retapamulin Market Size by Region (2020-2025)
4.2 Global Retapamulin Annual Revenue by Country/Region (2020-2025)
4.3 Americas Retapamulin Market Size Growth (2020-2025)
4.4 APAC Retapamulin Market Size Growth (2020-2025)
4.5 Europe Retapamulin Market Size Growth (2020-2025)
4.6 Middle East & Africa Retapamulin Market Size Growth (2020-2025)

5 AMERICAS

5.1 Americas Retapamulin Market Size by Country (2020-2025)
5.2 Americas Retapamulin Market Size by Type (2020-2025)
5.3 Americas Retapamulin Market Size by Application (2020-2025)
5.4 United States
5.5 Canada
5.6 Mexico
5.7 Brazil

6 APAC

6.1 APAC Retapamulin Market Size by Region (2020-2025)
6.2 APAC Retapamulin Market Size by Type (2020-2025)
6.3 APAC Retapamulin Market Size by Application (2020-2025)
6.4 China
6.5 Japan
6.6 South Korea
6.7 Southeast Asia
6.8 India
6.9 Australia

7 EUROPE

7.1 Europe Retapamulin Market Size by Country (2020-2025)
7.2 Europe Retapamulin Market Size by Type (2020-2025)
7.3 Europe Retapamulin Market Size by Application (2020-2025)
7.4 Germany
7.5 France
7.6 UK
7.7 Italy
7.8 Russia

8 MIDDLE EAST & AFRICA

8.1 Middle East & Africa Retapamulin by Region (2020-2025)
8.2 Middle East & Africa Retapamulin Market Size by Type (2020-2025)
8.3 Middle East & Africa Retapamulin Market Size by Application (2020-2025)
8.4 Egypt
8.5 South Africa
8.6 Israel
8.7 Turkey
8.8 GCC Countries

9 MARKET DRIVERS, CHALLENGES AND TRENDS

9.1 Market Drivers & Growth Opportunities
9.2 Market Challenges & Risks
9.3 Industry Trends

10 GLOBAL RETAPAMULIN MARKET FORECAST

10.1 Global Retapamulin Forecast by Region (2026-2031)
  10.1.1 Global Retapamulin Forecast by Region (2026-2031)
  10.1.2 Americas Retapamulin Forecast
  10.1.3 APAC Retapamulin Forecast
  10.1.4 Europe Retapamulin Forecast
  10.1.5 Middle East & Africa Retapamulin Forecast
10.2 Americas Retapamulin Forecast by Country (2026-2031)
  10.2.1 United States Market Retapamulin Forecast
  10.2.2 Canada Market Retapamulin Forecast
  10.2.3 Mexico Market Retapamulin Forecast
  10.2.4 Brazil Market Retapamulin Forecast
10.3 APAC Retapamulin Forecast by Region (2026-2031)
  10.3.1 China Retapamulin Market Forecast
  10.3.2 Japan Market Retapamulin Forecast
  10.3.3 Korea Market Retapamulin Forecast
  10.3.4 Southeast Asia Market Retapamulin Forecast
  10.3.5 India Market Retapamulin Forecast
  10.3.6 Australia Market Retapamulin Forecast
10.4 Europe Retapamulin Forecast by Country (2026-2031)
  10.4.1 Germany Market Retapamulin Forecast
  10.4.2 France Market Retapamulin Forecast
  10.4.3 UK Market Retapamulin Forecast
  10.4.4 Italy Market Retapamulin Forecast
  10.4.5 Russia Market Retapamulin Forecast
10.5 Middle East & Africa Retapamulin Forecast by Region (2026-2031)
  10.5.1 Egypt Market Retapamulin Forecast
  10.5.2 South Africa Market Retapamulin Forecast
  10.5.3 Israel Market Retapamulin Forecast
  10.5.4 Turkey Market Retapamulin Forecast
10.6 Global Retapamulin Forecast by Type (2026-2031)
10.7 Global Retapamulin Forecast by Application (2026-2031)
  10.7.1 GCC Countries Market Retapamulin Forecast

11 KEY PLAYERS ANALYSIS

11.1 Almirall
  11.1.1 Almirall Company Information
  11.1.2 Almirall Retapamulin Product Offered
  11.1.3 Almirall Retapamulin Revenue, Gross Margin and Market Share (2020-2025)
  11.1.4 Almirall Main Business Overview
  11.1.5 Almirall Latest Developments

12 RESEARCH FINDINGS AND CONCLUSION

List Of Tables

LIST OF TABLES

Table 1. Retapamulin Market Size CAGR by Region (2020 VS 2024 VS 2031) & ($ millions)
Table 2. Retapamulin Annual Sales CAGR by Country/Region (2020, 2024 & 2031) & ($ millions)
Table 3. Major Players of 1% ointment(15-gram tubes)
Table 4. Major Players of 1% ointment(30-gram tubes)
Table 5. Retapamulin Market Size CAGR by Type (2020 VS 2024 VS 2031) & ($ millions)
Table 6. Global Retapamulin Market Size by Type (2020-2025) & ($ millions)
Table 7. Global Retapamulin Market Size Market Share by Type (2020-2025)
Table 8. Retapamulin Market Size CAGR by Application (2020 VS 2024 VS 2031) & ($ millions)
Table 9. Global Retapamulin Market Size by Application (2020-2025) & ($ millions)
Table 10. Global Retapamulin Market Size Market Share by Application (2020-2025)
Table 11. Global Retapamulin Revenue by Player (2020-2025) & ($ millions)
Table 12. Global Retapamulin Revenue Market Share by Player (2020-2025)
Table 13. Retapamulin Key Players Head office and Products Offered
Table 14. Retapamulin Concentration Ratio (CR3, CR5 and CR10) & (2023-2025)
Table 15. New Products and Potential Entrants
Table 16. Mergers & Acquisitions, Expansion
Table 17. Global Retapamulin Market Size by Region (2020-2025) & ($ millions)
Table 18. Global Retapamulin Market Size Market Share by Region (2020-2025)
Table 19. Global Retapamulin Revenue by Country/Region (2020-2025) & ($ millions)
Table 20. Global Retapamulin Revenue Market Share by Country/Region (2020-2025)
Table 21. Americas Retapamulin Market Size by Country (2020-2025) & ($ millions)
Table 22. Americas Retapamulin Market Size Market Share by Country (2020-2025)
Table 23. Americas Retapamulin Market Size by Type (2020-2025) & ($ millions)
Table 24. Americas Retapamulin Market Size Market Share by Type (2020-2025)
Table 25. Americas Retapamulin Market Size by Application (2020-2025) & ($ millions)
Table 26. Americas Retapamulin Market Size Market Share by Application (2020-2025)
Table 27. APAC Retapamulin Market Size by Region (2020-2025) & ($ millions)
Table 28. APAC Retapamulin Market Size Market Share by Region (2020-2025)
Table 29. APAC Retapamulin Market Size by Type (2020-2025) & ($ millions)
Table 30. APAC Retapamulin Market Size by Application (2020-2025) & ($ millions)
Table 31. Europe Retapamulin Market Size by Country (2020-2025) & ($ millions)
Table 32. Europe Retapamulin Market Size Market Share by Country (2020-2025)
Table 33. Europe Retapamulin Market Size by Type (2020-2025) & ($ millions)
Table 34. Europe Retapamulin Market Size by Application (2020-2025) & ($ millions)
Table 35. Middle East & Africa Retapamulin Market Size by Region (2020-2025) & ($ millions)
Table 36. Middle East & Africa Retapamulin Market Size by Type (2020-2025) & ($ millions)
Table 37. Middle East & Africa Retapamulin Market Size by Application (2020-2025) & ($ millions)
Table 38. Key Market Drivers & Growth Opportunities of Retapamulin
Table 39. Key Market Challenges & Risks of Retapamulin
Table 40. Key Industry Trends of Retapamulin
Table 41. Global Retapamulin Market Size Forecast by Region (2026-2031) & ($ millions)
Table 42. Global Retapamulin Market Size Market Share Forecast by Region (2026-2031)
Table 43. Global Retapamulin Market Size Forecast by Type (2026-2031) & ($ millions)
Table 44. Global Retapamulin Market Size Forecast by Application (2026-2031) & ($ millions)
Table 45. Almirall Details, Company Type, Retapamulin Area Served and Its Competitors
Table 46. Almirall Retapamulin Product Offered
Table 47. Almirall Retapamulin Revenue ($ million), Gross Margin and Market Share (2020-2025)
Table 48. Almirall Main Business
Table 49. Almirall Latest Developments

List Of Figures

LIST OF FIGURES

Figure 1. Retapamulin Report Years Considered
Figure 2. Research Objectives
Figure 3. Research Methodology
Figure 4. Research Process and Data Source
Figure 5. Global Retapamulin Market Size Growth Rate (2020-2031) ($ millions)
Figure 6. Retapamulin Sales by Geographic Region (2020, 2024 & 2031) & ($ millions)
Figure 7. Retapamulin Sales Market Share by Country/Region (2024)
Figure 8. Retapamulin Sales Market Share by Country/Region (2020, 2024 & 2031)
Figure 9. Global Retapamulin Market Size Market Share by Type in 2024
Figure 10. Retapamulin in Hospital
Figure 11. Global Retapamulin Market: Hospital (2020-2025) & ($ millions)
Figure 12. Retapamulin in Drug store
Figure 13. Global Retapamulin Market: Drug store (2020-2025) & ($ millions)
Figure 14. Global Retapamulin Market Size Market Share by Application in 2024
Figure 15. Global Retapamulin Revenue Market Share by Player in 2024
Figure 16. Global Retapamulin Market Size Market Share by Region (2020-2025)
Figure 17. Americas Retapamulin Market Size 2020-2025 ($ millions)
Figure 18. APAC Retapamulin Market Size 2020-2025 ($ millions)
Figure 19. Europe Retapamulin Market Size 2020-2025 ($ millions)
Figure 20. Middle East & Africa Retapamulin Market Size 2020-2025 ($ millions)
Figure 21. Americas Retapamulin Value Market Share by Country in 2024
Figure 22. United States Retapamulin Market Size Growth 2020-2025 ($ millions)
Figure 23. Canada Retapamulin Market Size Growth 2020-2025 ($ millions)
Figure 24. Mexico Retapamulin Market Size Growth 2020-2025 ($ millions)
Figure 25. Brazil Retapamulin Market Size Growth 2020-2025 ($ millions)
Figure 26. APAC Retapamulin Market Size Market Share by Region in 2024
Figure 27. APAC Retapamulin Market Size Market Share by Type (2020-2025)
Figure 28. APAC Retapamulin Market Size Market Share by Application (2020-2025)
Figure 29. China Retapamulin Market Size Growth 2020-2025 ($ millions)
Figure 30. Japan Retapamulin Market Size Growth 2020-2025 ($ millions)
Figure 31. South Korea Retapamulin Market Size Growth 2020-2025 ($ millions)
Figure 32. Southeast Asia Retapamulin Market Size Growth 2020-2025 ($ millions)
Figure 33. India Retapamulin Market Size Growth 2020-2025 ($ millions)
Figure 34. Australia Retapamulin Market Size Growth 2020-2025 ($ millions)
Figure 35. Europe Retapamulin Market Size Market Share by Country in 2024
Figure 36. Europe Retapamulin Market Size Market Share by Type (2020-2025)
Figure 37. Europe Retapamulin Market Size Market Share by Application (2020-2025)
Figure 38. Germany Retapamulin Market Size Growth 2020-2025 ($ millions)
Figure 39. France Retapamulin Market Size Growth 2020-2025 ($ millions)
Figure 40. UK Retapamulin Market Size Growth 2020-2025 ($ millions)
Figure 41. Italy Retapamulin Market Size Growth 2020-2025 ($ millions)
Figure 42. Russia Retapamulin Market Size Growth 2020-2025 ($ millions)
Figure 43. Middle East & Africa Retapamulin Market Size Market Share by Region (2020-2025)
Figure 44. Middle East & Africa Retapamulin Market Size Market Share by Type (2020-2025)
Figure 45. Middle East & Africa Retapamulin Market Size Market Share by Application (2020-2025)
Figure 46. Egypt Retapamulin Market Size Growth 2020-2025 ($ millions)
Figure 47. South Africa Retapamulin Market Size Growth 2020-2025 ($ millions)
Figure 48. Israel Retapamulin Market Size Growth 2020-2025 ($ millions)
Figure 49. Turkey Retapamulin Market Size Growth 2020-2025 ($ millions)
Figure 50. GCC Countries Retapamulin Market Size Growth 2020-2025 ($ millions)
Figure 51. Americas Retapamulin Market Size 2026-2031 ($ millions)
Figure 52. APAC Retapamulin Market Size 2026-2031 ($ millions)
Figure 53. Europe Retapamulin Market Size 2026-2031 ($ millions)
Figure 54. Middle East & Africa Retapamulin Market Size 2026-2031 ($ millions)
Figure 55. United States Retapamulin Market Size 2026-2031 ($ millions)
Figure 56. Canada Retapamulin Market Size 2026-2031 ($ millions)
Figure 57. Mexico Retapamulin Market Size 2026-2031 ($ millions)
Figure 58. Brazil Retapamulin Market Size 2026-2031 ($ millions)
Figure 59. China Retapamulin Market Size 2026-2031 ($ millions)
Figure 60. Japan Retapamulin Market Size 2026-2031 ($ millions)
Figure 61. Korea Retapamulin Market Size 2026-2031 ($ millions)
Figure 62. Southeast Asia Retapamulin Market Size 2026-2031 ($ millions)
Figure 63. India Retapamulin Market Size 2026-2031 ($ millions)
Figure 64. Australia Retapamulin Market Size 2026-2031 ($ millions)
Figure 65. Germany Retapamulin Market Size 2026-2031 ($ millions)
Figure 66. France Retapamulin Market Size 2026-2031 ($ millions)
Figure 67. UK Retapamulin Market Size 2026-2031 ($ millions)
Figure 68. Italy Retapamulin Market Size 2026-2031 ($ millions)
Figure 69. Russia Retapamulin Market Size 2026-2031 ($ millions)
Figure 70. Egypt Retapamulin Market Size 2026-2031 ($ millions)
Figure 71. South Africa Retapamulin Market Size 2026-2031 ($ millions)
Figure 72. Israel Retapamulin Market Size 2026-2031 ($ millions)
Figure 73. Turkey Retapamulin Market Size 2026-2031 ($ millions)
Figure 74. Global Retapamulin Market Size Market Share Forecast by Type (2026-2031)
Figure 75. Global Retapamulin Market Size Market Share Forecast by Application (2026-2031)
Figure 76. GCC Countries Retapamulin Market Size 2026-2031 ($ millions)